Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Interferon beta-1a SubQ injection Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Interferon beta-1a SubQ injection Treatment Report

Brand Names: Rebif

What is Interferon beta-1a SubQ injection? Interferon beta-1a is an immunomodulator used to prevent episodes of symptoms and slow the development of disability in patients with relapsing-remitting multiple sclerosis. It comes as a solution to inject subcutaneously (under the skin) three times a week, ideally the same 3 days each week.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

1663 patients in the community are taking or have taken Interferon beta-1a SubQ injection.

Top 10 (Show all)

Reason # Patients Percentage of patients
Slow my MS progress 1249 75%
Multiple Sclerosis (MS) 68 4%
Other 46 2%
Stiffness/Spasticity 16 <1%
General health 14 <1%
Fatigue 13 <1%
disease-related symptoms 10 <1%
Don't know 5 <1%
Mobility 5 <1%
Support another treatment 2 <1%

Other treatments patients are taking for Slow my MS progress include Glatiramer acetate, Interferon beta-1a IM Injection, and Interferon beta-1b SubQ Injection.

Dosages

Based on the patients currently taking Interferon beta-1a SubQ injection.

Top 10 (Show all)

All (Show top 10)

  0.44 mg as needed 132mcg weekly 22 mcg/0.5 mL as needed 22mcg/0.5mL as needed 3 44mcg/0.5mL as needed 3 times a week 44 mcg/0.5 mL all the time (24/7) 44 mcg/0.5 mL as needed 44mcg/0.5mL as needed 44 mcg all the time (24/7) 44mcg as needed 44 mg all the time (24/7) 44mg as needed - as needed as needed daily monthly weekly 0.14 mcg 0.44 mg weekly 0.5 mcg weekly 0.5 mg weekly 0.22 mg 0.25 mcg 0.25 mg 1 g weekly 1 weekly 0.3 mcg 0.3 mg 1.1 weekly 0.44 mcg 0.5 mcg 0.44 0.44 mcg 0.44 mg 0.5 mcg 0.3 mcg daily 0.3 mg daily 0.8 mcg 0.75 mg 1 mcg 3 mcg weekly 3 mg weekly 3 weekly 1 1 mcg 1 mg 4.4 mcg weekly 30 mcg/0.5 mL monthly 1 mL daily 8.8 mcg weekly 3 mcg 3 mcg 3 mg 4.4 mcg 15 mcg weekly 20 mg weekly 3 mg daily 22 mcg/0.5 mL weekly 22 mcg weekly 22 mg weekly 26.4 mcg weekly 10 mcg 30 mcg/0.5 mL weekly 30 mcg weekly 30 mg weekly 8.8 mg 33 mg weekly 10 12 mcg 40 mcg weekly 40.5 mcg weekly 44 mcg/0.5 mL weekly 44 mcg weekly 44 mg weekly 44 weekly 60 mg weekly 8.8 mcg daily 8.8 mg daily 22 mcg 22 mcg/0.5 mL 22 mcg/0.5 mL 3 times a week 3 x 22 mcg/0.5 mL weekly 66 mcg weekly 66 mg weekly 10 mg daily 22 22 mcg 22 mg 25 mg 2 x 44 mcg/0.5 mL weekly 88 mcg weekly 30 mcg/0.5 mL 3 times a week 33 mcg 99 mcg weekly 30 mcg 112 mcg weekly 40 mcg 120 mg weekly 12 x 44 mcg/0.5 mL monthly 126 mcg weekly 44 mcg 44 mcg/0.5 mL 3 times a week 132 mcg weekly 132 mg weekly 3 x 44 mcg/0.5 mL weekly 40 41 mcg 43 mg 152 mg weekly 22 mcg/0.5 mL daily 22 mcg daily 44 44 g 44 mcg 44 mg 4 x 44 mcg/0.5 mL weekly 30 mcg/0.5 mL daily 30 mcg daily 6 x 44 mcg/0.5 mL weekly 100 mcg 300 weekly 44 mcg/0.5 mL daily 44 mcg/0.5 mL one time 44 mcg daily 132 mcg 138 mcg 125 132 mcg 144 mg 100 mcg daily 200 mcg 200 mg 132 mcg daily 3 x 44 mcg/0.5 mL daily 321 mcg 300 mg 200 g daily 250 mcg daily 500 mcg 300 other daily 44 mcg
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 25 Number of Patients: 25 1 Number of Patients: 1 4 Number of Patients: 4 11 Number of Patients: 11 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 4 Number of Patients: 4 16 Number of Patients: 16 1 Number of Patients: 1 24 Number of Patients: 24 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 8 Number of Patients: 8 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 2 Number of Patients: 2 3 Number of Patients: 3 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 7 Number of Patients: 7 3 Number of Patients: 3 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 63 Number of Patients: 63 35 Number of Patients: 35 16 Number of Patients: 16 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 8 Number of Patients: 8 1 Number of Patients: 1 16 Number of Patients: 16 31 Number of Patients: 31 4 Number of Patients: 4 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 87 Number of Patients: 87 48 Number of Patients: 48 34 Number of Patients: 34 17 Number of Patients: 17 184 Number of Patients: 184 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 13 Number of Patients: 13 2 Number of Patients: 2 19 Number of Patients: 19 1 Number of Patients: 1 36 Number of Patients: 36 77 Number of Patients: 77 1 Number of Patients: 1 2 Number of Patients: 2 6 Number of Patients: 6 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 87 Number of Patients: 87 1 Number of Patients: 1 17 Number of Patients: 17 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Interferon beta-1a SubQ injection or how long patients were taking Interferon beta-1a SubQ injection before stopping.

Currently Taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
4
24
43
92
115
198

Stopped Taking Interferon beta-1a SubQ injection

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
23
61
78
107
88
171
Why Patients Stopped Taking Interferon beta-1a SubQ injection (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 275 50% Side effects too severe: 50%
Did not seem to work 185 34% Did not seem to work: 34%
Doctor's advice 130 24% Doctor's advice: 24%
Other 89 16% Other: 16%
Personal research 27 5% Personal research: 5%
Expense 21 4% Expense: 4%
Not indicated 15 3% Not indicated: 3%
Course of treatment ended 9 2% Course of treatment ended: 2%

Patient Reported Evaluations

Results from 259 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 16% 34
Moderate 14% 31
Slight 13% 29
None 11% 24
Can't tell 45% 98

Slow my MS progress

Side-effects (as an overall problem)

Severe 15% 39
Moderate 36% 94
Mild 38% 99
None 10% 27

Top reported side-effects include: Injection site redness, Muscle ache, whole body, Chills/fever

Summary results are based on 259 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 259)

  • A Prayer a day
    Sex: F
    Sensation: Moderate
    Overall: Moderate
    Cognition: severe
    Vision: moderate
    Speech: moderate
    Swallowing: mild
    Upper limb: moderate
    Walking: moderate
    See profile
  • by A Prayer a day
    Jun 22, 2009
  • EfficacyModerate
  • Side-effectsNone
  • Slow my MS progress
Advice/Tips
Do what I do. Take Motrin and your Rebif shot just before bedtime and you will sleep right through it. I guess I do take sleep meds.

  • anne ball
    Sex: F
    Sensation: Moderate
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: moderate
    Swallowing: moderate
    Upper limb: moderate
    Walking: moderate
    See profile
  • anne ball
  • by anne ball
    May 23, 2009
  • EfficacyCan't tell
  • Side-effectsModerate
  • Slow my MS progress
Advice/Tips
massage cold pack around injection site prior & after injection

See all evaluation results for Interferon beta-1a SubQ injection

Report created on November 07, 2009.